National Institutes of Health: Neoplasms trials

The registry lists 377 Neoplasms studies with National Institutes of Health as lead sponsor. 36 are open to participants now and 81 have results posted.

Early Phase 1 3Phase 1 197Phase 2 99Phase 3 4Phase 4 1No phase 96(a study in two phases counts in both)

Studies

Page 3 of 4. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pharmacokinetic Studies Participation SurveyCompletedNCT00923468
• Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
• Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to TreatmentCompletedNCT00880282Phase 1
• The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot StudyCompletedNCT00824278
• Community Cancer Centers Pilot Patient SurveyCompletedNCT00786656
• Reactions to Disease Risk InformationCompletedNCT00774254Not applicable
• Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00678769Phase 1
• AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor CancersCompletedNCT00678132Phase 1
• Aflibercept in Treating Young Patients With Relapsed or Refractory Solid TumorsCompletedNCT00622414Phase 1
• IMC-A12 in Treating Young Patients With Relapsed or Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor or Other Solid TumorCompletedNCT00609141Phase 1
• Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by SurgeryCompletedNCT00576654Phase 1
• Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaCompletedNCT00458731Phase 1
• Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine TumorsStatus unknownNCT00454376
• Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi DeltaCompletedNCT00443313
• Human Papillomavirus (HPV) and Risk of Cervical Precancer and CancerCompletedNCT00435214
• Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00415324Phase 1
• Cancer Risk in X-Ray Technologists: Second SurveyCompletedNCT00410475
• Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00408655Phase 1
• 3-AP in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00390052Phase 1
• Sunitinib in Treating Young Patients With Refractory Solid TumorsCompletedNCT00387920Phase 1
• AFP464 in Treating Patients With Advanced Solid TumorsTerminatedNCT00369200Phase 1
• Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaCompletedNCT00363272Phase 1
• Agriculture Health StudyActive, not recruitingNCT00352924
• Case-Control Study of Pesticides and Childhood LeukemiaCompletedNCT00342888
• Nutrition Intervention Trials in Linxian Follow-up StudyCompletedNCT00342654
• Costa Rican Natural History Study of HPV and Cervical NeoplasiaTerminatedNCT00342173
• The Second Multicenter Hemophilia Cohort StudyCompletedNCT00341705
• Studying Normal Breast Tissue and Cancer RiskCompletedNCT00341692
• Early Detection of Esophageal CancerTerminatedNCT00341523
• Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With GeneticsCompletedNCT00341458
• Esophageal Cancer Genetics StudiesCompletedNCT00341276
• Prostate Lung Colorectal and Ovarian (PLCO) Cancer Screening TrialActive, not recruitingNCT00339495
• Ixabepilone in Treating Young Patients With Refractory Solid TumorsCompletedNCT00331643Phase 2
• AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS TumorsCompletedNCT00326664Phase 1
• Vorinostat and Alvocidib in Treating Patients With Advanced Solid TumorsCompletedNCT00324480Phase 1
• Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsCompletedNCT00303940Phase 1
• Diffusion Tensor MRI to Distinguish Brain Tumor Recurrence From Radiation NecrosisCompletedNCT00285324
• Combination Chemotherapy in Treating Young Patients With Advanced Solid TumorsCompletedNCT00281944Phase 1
• Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced CancerCompletedNCT00244972Phase 1
• Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaCompletedNCT00217412Phase 1
• SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00121290Phase 1
• 17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00121264Phase 1
• 17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00119236Phase 1
• A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1aCompletedNCT00117013Phase 1
• Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid TumorsTerminatedNCT00112684Phase 1
• Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain TumorsTerminatedNCT00110032Phase 1
• SJG-136 in Treating Patients With Advanced Solid TumorsCompletedNCT00103220Phase 1
• Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
• Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS TumorsCompletedNCT00100880Phase 1
• CCI-779 and EKB-569 in Treating Patients With Advanced Solid TumorsCompletedNCT00098501Phase 1
• Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00095914Phase 1
• Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid TumorsCompletedNCT00093821Phase 1
• Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
• Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
• Bortezomib in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNCT00091117Phase 1
• Acupuncture for Women's Health ConditionsCompletedNCT00090389Phase 1
• EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
• Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid TumorsTerminatedNCT00086983Phase 1
• Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid TumorsTerminatedNCT00086970Phase 1
• Bevacizumab in Treating Young Patients With Refractory Solid TumorsCompletedNCT00085111Phase 1
• Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine TumorsTerminatedNCT00084461Phase 2
• Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell NeoplasmsCompletedNCT00082784Phase 1
• Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid TumorsCompletedNCT00080990Phase 1
• T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic MalignanciesCompletedNCT00080925Phase 1
• GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00078962Phase 1
• Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsCompletedNCT00077454Phase 1
• Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine TumorsCompletedNCT00075439Phase 2
• Surgery Versus Radiosurgery to Treat Metastatic Brain TumorsCompletedNCT00075166Phase 4
• Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid TumorsCompletedNCT00074321Phase 1
• Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid TumorsCompletedNCT00072436Phase 1
• A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced MalignanciesCompletedNCT00068484Phase 1
• Acupuncture for Shortness of Breath in Cancer PatientsCompletedNCT00067691Not applicable
• Voriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyCompletedNCT00066599Phase 2
• Radiation Therapy and the Natural History of Childhood CancersCompletedNCT00064883
• Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00064311Phase 1/2
• Cilengitide in Treating Children With Refractory Primary Brain TumorsCompletedNCT00063973Phase 1
• Irinotecan and Thalidomide in Treating Patients With Advanced Solid TumorsCompletedNCT00062127Phase 1
• Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid TumorsCompletedNCT00055809Phase 2
• Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid TumorsCompletedNCT00054548Phase 1
• Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial NeoplasiaCompletedNCT00054041Phase 2
• FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaCompletedNCT00053963Phase 1
• Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsCompletedNCT00052780Phase 1
• Bortezomib and Docetaxel in Treating Patients With Advanced Solid TumorsTerminatedNCT00049088Phase 1
• Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00047047Phase 1
• E7389 in Treating Patients With Advanced Solid TumorsCompletedNCT00047034Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00046917Phase 1
• Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic RiskCompletedNCT00043472
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00042874Phase 1
• Brain Neoplasms, Leukemia and Petrochemical ExposuresCompletedNCT00042445
• Radiofrequency Ablation of Painful Soft Tissue NeoplasmsCompletedNCT00041886
• Gefitinib in Treating Children With Refractory Solid TumorsCompletedNCT00040781Phase 1
• Massage Therapy for Cancer-Related FatigueCompletedNCT00039793Phase 2
• Gefitinib and Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00039390Phase 1
• ABT-751 in Treating Young Patients With Refractory Solid TumorsCompletedNCT00036959Phase 1
• UCN-01 and Carboplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00036777Phase 1
• Acupuncture to Reduce Symptoms of Advanced Colorectal CancerCompletedNCT00034034Phase 1
• Study of Noni in Cancer PatientsCompletedNCT00033878Phase 1
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of ChildhoodCompletedNCT00030667Phase 2
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1